T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.

PLoS One · 2017 · PMC5495335 · PMID 28672038

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

An increasing trend in CD6 receptor expression is seen in Thnp and Th17 pol conditions over unstimulated cells.

also in 63,971 other papers

showed a trendno p-value reported

(B-D) showed a significance difference (p≤ 0.05) while (E-F) showed a trend for reduction with p values 0.1 and 0.2 respectively, when compared between Iso Ab and Itolizumab.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.